ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,351.475
-0.37%
Brent Oil
82.33
-0.07%
Bitcoin
60,826.85
-1.01%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pacira BioSciences Inc (PCRX)

  7. Pacira BioSciences Inc (PCRX) News

Pacira BioSciences (PCRX)

Pacira BioSciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PCRX
DateTimeSourceHeadlineSymbolCompany
10/05/202412:00GlobeNewswire Inc.Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029NASDAQ:PCRXPacira BioSciences Inc
08/05/202421:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
08/05/202421:05GlobeNewswire Inc.Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior NotesNASDAQ:PCRXPacira BioSciences Inc
07/05/202421:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PCRXPacira BioSciences Inc
07/05/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
07/05/202421:00GlobeNewswire Inc.Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase programNASDAQ:PCRXPacira BioSciences Inc
07/05/202413:00GlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
30/04/202413:00GlobeNewswire Inc.Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024NASDAQ:PCRXPacira BioSciences Inc
02/04/202413:00GlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
13/03/202411:00GlobeNewswire Inc.Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the KneeNASDAQ:PCRXPacira BioSciences Inc
06/03/202413:00GlobeNewswire Inc.Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
29/02/202420:33Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PCRXPacira BioSciences Inc
29/02/202413:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
29/02/202413:00GlobeNewswire Inc.Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:PCRXPacira BioSciences Inc
22/02/202413:00GlobeNewswire Inc.Pacira to Report 2023 Financial Results on Thursday February 29, 2024NASDAQ:PCRXPacira BioSciences Inc
15/02/202413:36GlobeNewswire Inc.Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After BunionectomyNASDAQ:PCRXPacira BioSciences Inc
07/02/202421:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
07/02/202413:00GlobeNewswire Inc.Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.NASDAQ:PCRXPacira BioSciences Inc
01/02/202415:45PR Newswire (US)G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball TeamsNASDAQ:PCRXPacira BioSciences Inc
04/01/202422:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
04/01/202422:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
04/01/202422:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
04/01/202422:18Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
04/01/202422:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
04/01/202422:00GlobeNewswire Inc.Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 RevenuesNASDAQ:PCRXPacira BioSciences Inc
03/01/202413:00GlobeNewswire Inc.Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PCRXPacira BioSciences Inc
21/12/202312:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCRXPacira BioSciences Inc
21/12/202312:30GlobeNewswire Inc.Pacira Appoints Frank D. Lee as Chief Executive OfficerNASDAQ:PCRXPacira BioSciences Inc
08/12/202300:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PCRXPacira BioSciences Inc
13/11/202314:41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCRXPacira BioSciences Inc
 Showing the most relevant articles for your search:NASDAQ:PCRX

Your Recent History

LSE
PET
Petrel Resources
LSE
GCM
Gcm Resources
LSE
BARC
Barclays
LSE
THUS
Thus
LSE
MARS
Marston's
LSE
TERN
Tern
LSE
SYME
Supply@me Capital
LSE
INSG
Insig Ai
LSE
PIER
Brighton Pier
LSE
GKP
Gulf Keystone Petroleum
LSE
HVO
Hvivo
LSE
W7L
Warpaint London
LSE
SFOR
S4 Capital
LSE
ZTF
Zotefoams
LSE
TRIN
Trinity Exploration & Pr...
LSE
XTR
Xtract Resources
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved